Wrong on a couple of counts, imo. But thanks for the wink
1. XPE revenues for Q4 were $0. See image which is a copy of the Q4 4C
2. The RAP comparison. It gets me every time. XPE gave guidance, on more than 1 occasion, first revenues would be in September. We have not had any confirmation if this has/hasn't happened. You would think, imo, if it had happened in September, XPE would be crowing about it. Do companies usually hide good news? In comparison, RAP management have said revenue will most likely occur after FDA approval. Not before. It is about meeting market expectations, particularly if the expectation has been set by the company itself. Do you see the subtlety?
XPE Lounge, page-863
Add OAK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.619M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 42973 | 1 |
View Market Depth
| Last trade - 16.12pm 01/11/2024 (20 minute delay) ? |
| OAK (ASX) Chart |
Day chart unavailable